HB4607, the SEEK HELP Act, is a federal “Good Samaritan” overdose response bill designed to encourage people to call for help during a drug overdose without fear that seeking aid will trigger drug-possession penalties. It creates protections for individuals who, in good faith and in a timely manner, seek medical assistance for themselves or another person experiencing a drug overdose. Those protections apply when the only basis for law enforcement learning of the possession is the act of seeking help, and they cover prosecution, civil asset forfeiture, and revocation of supervised release for simple possession of a controlled substance.
The bill also provides civil liability protections for people who administer an opioid overdose reversal drug, such as naloxone, in good faith during an emergency. It directs the Secretary of Health and Human Services, in consultation with the DEA, to run a public awareness campaign about these protections, and it allows federal JAG funds to support law-enforcement training on overdose Good Samaritan laws. In addition, it permits states receiving certain substance abuse block grants to use funds for public education, stakeholder training, and data-sharing on overdose response laws, and it requires a GAO report within two years to evaluate implementation, effectiveness, barriers, and best practices.
In practical terms, the bill would add a federal layer of immunity and outreach around overdose response, while leaving existing state protections in place if they are at least as protective. It would affect individuals with controlled-substance possession exposure, emergency responders, law enforcement, healthcare providers, poison control centers, and state and local governments administering public health and criminal justice programs. It also amends federal grant language to support education and training related to overdose emergencies.
The overall sentiment reflected by the bill’s sponsorship is strongly supportive of overdose prevention and harm reduction, with an emphasis on saving lives by reducing hesitation to call 9-1-1 or administer naloxone. The bill was introduced by a bipartisan group of House members, suggesting cross-party interest in the issue, but no committee debate, votes, or recorded opposition are available in the provided materials. Because there are no transcripts or vote totals, the public record here does not show formal controversy, though the subject matter commonly implicates tensions between public health goals and drug-enforcement concerns.
The main points of contention likely center on the scope of immunity, especially the limits on prosecution and civil forfeiture when controlled substances are present, and whether federal law should preempt weaker state laws. The bill narrows protections by excluding conduct involving warrants and by preserving liability for willful misconduct, gross negligence, reckless misconduct, and unrelated offenses. Supporters are likely to emphasize overdose survival, naloxone access, and reduced fear of calling for help; critics may focus on enforcement concerns, evidentiary issues, and whether such protections could be misused.
HB4607 would create a federal baseline of overdose Good Samaritan protections by shielding certain individuals from drug-possession prosecution, civil asset forfeiture, and supervised-release revocation when they seek medical assistance for an overdose in good faith and in a timely manner. It would also protect good-faith administration of opioid overdose reversal drugs from civil liability, while preserving state laws that already provide comparable immunity. The bill amends federal grant provisions to support training and public awareness campaigns and requires a GAO study of state implementation and outcomes, thereby influencing both criminal justice practice and public health outreach at the federal, state, and local levels.
The bill appears to have a generally favorable, life-saving public health orientation, with bipartisan sponsorship indicating broad political appeal. Because there are no committee transcripts or recorded votes in the provided materials, there is no documented floor or committee sentiment to measure beyond the bill’s text and sponsorship. The framing of the legislation suggests support for overdose response, naloxone use, and reducing barriers to emergency calls, with no formal recorded opposition in the available record.
The likely areas of disagreement are the balance between encouraging emergency calls and preserving drug-enforcement tools, the breadth of immunity from prosecution and civil forfeiture, and the extent of federal involvement in an area that often overlaps with state criminal law. Supporters would likely argue that fear of arrest deters people from calling for help during overdoses, while opponents may worry about limiting accountability, complicating evidence collection, or creating incentives for misuse. The bill addresses some of these concerns by excluding conduct tied to warrants and by preserving liability for serious misconduct and unrelated offenses.